Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Santen Pharmaceutical Co. Ltd.
DescriptionDual inhibitor of VEGF and PDGF
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor; Platelet derived growth factor receptor (PDGFR) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAge-related macular degeneration (AMD)
Indication DetailsTreat wet age-related macular degeneration (AMD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today